<SEC-DOCUMENT>0001839882-23-032888.txt : 20231205
<SEC-HEADER>0001839882-23-032888.hdr.sgml : 20231205
<ACCEPTANCE-DATETIME>20231205132702
ACCESSION NUMBER:		0001839882-23-032888
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20231205
DATE AS OF CHANGE:		20231205

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Haleon plc
		CENTRAL INDEX KEY:			0001900304
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-41411
		FILM NUMBER:		231465962

	BUSINESS ADDRESS:	
		STREET 1:		BUILDING 5, FIRST FLOOR
		STREET 2:		THE HEIGHTS
		CITY:			WEYBRIDGE
		STATE:			X0
		ZIP:			KT13 0NY
		BUSINESS PHONE:		44 1932 822000

	MAIL ADDRESS:	
		STREET 1:		BUILDING 5, FIRST FLOOR
		STREET 2:		THE HEIGHTS
		CITY:			WEYBRIDGE
		STATE:			X0
		ZIP:			KT13 0NY

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DRVW 2022 Ltd
		DATE OF NAME CHANGE:	20211217

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GSK Master Grantor Trust
		CENTRAL INDEX KEY:			0001990094
		IRS NUMBER:				256637335
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		2929 WALNUT STREET, SUITE 1700
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		44 208 0472 180

	MAIL ADDRESS:	
		STREET 1:		2929 WALNUT STREET, SUITE 1700
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: GSK Master Grantor Trust -->
          <cik>0001990094</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001900304</issuerCik>
      <issuerName>Haleon plc</issuerName>
      <secFileNumber>001-41411</secFileNumber>
      <issuerAddress>
        <com:street1>BUILDING 5, FIRST FLOOR, THE HEIGHTS</com:street1>
        <com:city>WEYBRIDGE SURREY</com:city>
        <com:stateOrCountry>X0</com:stateOrCountry>
        <com:zipCode>KT13 0NY</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>44-1932-822-000</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>GSK Master Grantor Trust</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>American Depositary Shares, each representing two ordinary shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>BNY Mellon Capital Markets LLC</name>
        <address>
          <com:street1>500 Grant Street</com:street1>
          <com:city>Pittsburgh</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>15258</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>404599</noOfUnitsSold>
      <aggregateMarketValue>3467413.43</aggregateMarketValue>
      <noOfUnitsOutstanding>9234573831</noOfUnitsOutstanding>
      <approxSaleDate>12/05/2023</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>American Depositary Shares, each representing two ordinary shares</securitiesClassTitle>
      <acquiredDate>07/18/2022</acquiredDate>
      <natureOfAcquisitionTransaction>The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Haleon plc</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>404599</amountOfSecuritiesAcquired>
      <paymentDate>07/18/2022</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>The Filer is not currently an affiliate of the Issuer, but was an affiliate during the preceding three months. The Number of Shares or Other Units Outstanding provided above represents the number of outstanding ordinary shares (and not American Depositary Shares).</remarks>
    <noticeSignature>
      <noticeDate>12/05/2023</noticeDate>
      <signature>/s/ Christopher Carroll</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
